AIIMS Delhi Uses Blockchain Technology to Complete Recruitment for Over 460 Faculty Posts

IMT News Desk
IMT News Desk
· 2 min read
AIIMS Delhi uses blockchain-based recruitment to fill over 460 faculty posts, boosting transparency, security and speed in hiring.

The All India Institute of Medical Sciences (AIIMS), New Delhi, has completed one of its largest faculty recruitment drives using blockchain-based digital technology, filling more than 460 vacant posts across over 50 disciplines at AIIMS New Delhi and the AIIMS–Central Armed Police Forces Institute of Medical Sciences (CAPFIMS) campus in Maidan Garhi. The appointments span positions from Assistant Professor to Professor, and are expected to significantly strengthen the institutes’ capacity in patient care, teaching and medical research. The six‑month selection process attracted over 3,200 applications for 265 posts at AIIMS New Delhi and 199 posts at the AIIMS–CAPFIMS campus, reflecting the scale and importance of the exercise.

According to AIIMS, blockchain technology was integrated into the recruitment workflow to enhance transparency, data security and confidentiality at every stage of the selection process. Candidates’ marks were digitally locked using one‑time passwords and stored on a tamper‑resistant digital ledger, after which the software generated the final merit list based on these scores and predefined algorithms, with no human intervention except in cases where tie‑breaking was required. Institute officials said this approach reduced manual handling of evaluation records, minimised the scope for errors and ensured that the final results could be declared swiftly while maintaining the integrity and credibility of the process.

The adoption of blockchain for recruitment marks a significant step in AIIMS Delhi’s broader push towards technology‑enabled governance and institutional reform. By demonstrating that emerging digital tools can be used to run secure, transparent and efficient recruitment systems at scale, the institute has set a precedent for other medical and higher education institutions across the country. The newly appointed faculty members are expected to play a key role in expanding specialised clinical services, mentoring the next generation of healthcare professionals and advancing cutting‑edge research in their respective fields, further consolidating AIIMS’s position as a premier centre of excellence in Indian healthcare and medical education.

Read Next

PM Modi to Dedicate Key Healthcare Infrastructure Projects to Nation on July 17: PGIMER Director
News
July 14, 2026

PM Modi to Dedicate Key Healthcare Infrastructure Projects to Nation on July 17: PGIMER Director

Prime Minister Narendra Modi will dedicate several key healthcare infrastructure projects to the nation on July 17, according to PGIMER Director Dr Vivek Lal. The projects include the Advanced Mother and Child Centre, the Advanced Neurosciences Centre and a new Critical Care Block, all of which are expected to strengthen tertiary care services and expand […]
Article by: IMT News Desk
OneSource Specialty Pharma and Formycon AG Announce Strategic Manufacturing Partnership for Biosimilars
News
July 14, 2026

OneSource Specialty Pharma and Formycon AG Announce Strategic Manufacturing Partnership for Biosimilars

OneSource Specialty Pharma Limited and Formycon AG have announced a strategic manufacturing partnership for biosimilars, bringing together Formycon’s biosimilar development expertise and OneSource’s integrated biologics manufacturing capabilities to support global markets. Under the agreement, OneSource will serve as a strategic manufacturing partner for Formycon and provide both drug substance and drug product manufacturing from its […]
Article by: IMT News Desk
FDA Approves At-Home Starter Dose of Eisai-Biogen’s Alzheimer’s Drug Leqembi
News
July 14, 2026

FDA Approves At-Home Starter Dose of Eisai-Biogen’s Alzheimer’s Drug Leqembi

The U.S. Food and Drug Administration has approved an at-home starting dose of Eisai and Biogen’s Alzheimer’s drug Leqembi, allowing some patients to begin treatment with injections administered by themselves or a caregiver. The decision expands access to the drug’s subcutaneous formulation, which can now be used as a starter dose rather than only after […]
Article by: IMT News Desk
Emcure Pharmaceuticals Consolidates Full Ownership of Gennova Amid Leadership Transition
News
July 14, 2026

Emcure Pharmaceuticals Consolidates Full Ownership of Gennova Amid Leadership Transition

Emcure Pharmaceuticals Limited has announced the consolidation of its shareholding in biopharma subsidiary Gennova Biopharmaceuticals Limited, alongside a leadership transition, as it sharpens its focus on biologics and biosimilars. The company is acquiring the entire 12.05% minority stake in Gennova held by Dr Sanjay Singh and others, taking its ownership to 100% and making Gennova […]
Article by: IMT News Desk